164 related articles for article (PubMed ID: 29491080)
21. Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer.
Mourton SM; Temple LK; Abu-Rustum NR; Gemignani ML; Sonoda Y; Bochner BH; Barakat RR; Chi DS
Gynecol Oncol; 2005 Dec; 99(3):608-14. PubMed ID: 16153697
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of effectiveness of the PlasmaJet surgical device in the treatment of advanced stage ovarian cancer (PlaComOv-study): study protocol of a randomized controlled trial in the Netherlands.
Nieuwenhuyzen-de Boer GM; Hofhuis W; Reesink-Peters N; Ewing-Graham PC; Schoots IG; Beltman JJ; Piek JMJ; Baalbergen A; Kooi GS; van Haaften A; van Huisseling H; Haans L; Dorman M; van Beekhuizen HJ
BMC Cancer; 2019 Jan; 19(1):58. PubMed ID: 30642296
[TBL] [Abstract][Full Text] [Related]
23. Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome.
Bristow RE; Peiretti M; Gerardi M; Zanagnolo V; Ueda S; Diaz-Montes T; Giuntoli RL; Maggioni A
Gynecol Oncol; 2009 Aug; 114(2):173-7. PubMed ID: 19482344
[TBL] [Abstract][Full Text] [Related]
24. Positive peritoneal cytology at interval surgery is a poor prognostic factor in patients with stage T3c advanced ovarian carcinoma: A retrospective study.
Nagasaka K; Kawana K; Tomio K; Tsuruga T; Mori-Uchino M; Miura S; Tanikawa M; Miyamoto Y; Ikeda Y; Sone K; Adachi K; Matsumoto Y; Arimoto T; Oda K; Osuga Y; Fujii T
J Obstet Gynaecol Res; 2015 May; 41(5):755-62. PubMed ID: 25421004
[TBL] [Abstract][Full Text] [Related]
25. Transumbilical defunctioning ileostomy: A new approach for patients at risks of anastomotic leakage after laparoscopic low anterior resection.
Eto K; Omura N; Haruki K; Uno Y; Ohkuma M; Nakajima S; Anan T; Kosuge M; Fujita T; Ishida K; Yanaga K
Anticancer Res; 2013 Nov; 33(11):5011-5. PubMed ID: 24222144
[TBL] [Abstract][Full Text] [Related]
26. Morbidity of rectosigmoid resection in cytoreductive surgery for ovarian cancer. Risk factor analysis.
Fournier M; Huchon C; Ngo C; Bensaid C; Bats AS; Combe P; le FrèreBelda MA; Fournier L; Berger A; Lecuru F
Eur J Surg Oncol; 2018 Jun; 44(6):750-753. PubMed ID: 29580734
[TBL] [Abstract][Full Text] [Related]
27. Recurrence and Survival Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Small Bowel Adenocarcinoma.
Saxena A; Valle SJ; Liauw W; Morris DL
Anticancer Res; 2017 Oct; 37(10):5737-5742. PubMed ID: 28982894
[TBL] [Abstract][Full Text] [Related]
28. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant chemotherapy combined with interval cytoreductive surgery in ovarian cancer.
Li X; Du X
J BUON; 2019; 24(5):2035-2040. PubMed ID: 31786872
[TBL] [Abstract][Full Text] [Related]
30. AGO Score As a Predictor of Surgical Outcome at Secondary Cytoreduction in Patients with Ovarian Cancer.
Muallem MZ; Gasimli K; Richter R; Almuheimid J; Nasser S; Braicu EI; Sehouli J
Anticancer Res; 2015 Jun; 35(6):3423-9. PubMed ID: 26026105
[TBL] [Abstract][Full Text] [Related]
31. Oncologic Concerns regarding Laparoscopic Cytoreductive Surgery in Patients with Advanced Ovarian Cancer Submitted to Neoadjuvant Chemotherapy.
Favero G; Macerox N; Pfiffer T; Köhler C; da Costa Miranda V; Estevez Diz Mdel P; Fukushima JT; Baracat EC; Carvalho JP
Oncology; 2015; 89(3):159-66. PubMed ID: 25968072
[TBL] [Abstract][Full Text] [Related]
32. Cytoreductive surgery for stage IV epithelial ovarian cancer.
Zang RY; Zhang ZY; Cai SM; Li ZT; Chen J; Tang MQ; Liu Q
J Exp Clin Cancer Res; 1999 Dec; 18(4):449-54. PubMed ID: 10746968
[TBL] [Abstract][Full Text] [Related]
33. Value of Diaphragmatic Surgery During Interval Debulking Surgery.
Pelissier A; Franke O; Darai E; Houvenaeghel G; Chereau E; Rouzier R
Anticancer Res; 2018 Jan; 38(1):411-416. PubMed ID: 29277802
[TBL] [Abstract][Full Text] [Related]
34. Geriatric co-management leads to safely performed cytoreductive surgery in older women with advanced stage ovarian cancer treated at a tertiary care cancer center.
Filippova OT; Chi DS; Long Roche K; Sonoda Y; Zivanovic O; Gardner GJ; Tew WP; O'Cearbhaill R; Sarraf S; Sun SW; Alexander K; Korc-Grodzicki B; Shahrokni A
Gynecol Oncol; 2019 Jul; 154(1):77-82. PubMed ID: 31078241
[TBL] [Abstract][Full Text] [Related]
35. Survival outcomes after extensive cytoreductive surgery and selective neoadjuvant chemotherapy according to institutional criteria in bulky stage IIIC and IV epithelial ovarian cancer.
Lim MC; Yoo HJ; Song YJ; Seo SS; Kang S; Kim SH; Yoo CW; Park SY
J Gynecol Oncol; 2017 Jul; 28(4):e48. PubMed ID: 28541636
[TBL] [Abstract][Full Text] [Related]
36. Oncologic outcomes after secondary surgery in recurrent clear-cell carcinoma of the ovary.
Kajiyama H; Suzuki S; Yoshikawa N; Kawai M; Shibata K; Nagasaka T; Kikkawa F
Int J Gynecol Cancer; 2019 Jun; 29(5):910-915. PubMed ID: 30839284
[TBL] [Abstract][Full Text] [Related]
37. Loop-ileostomy reversal-patient-related characteristics influencing time to closure.
Gustafsson CP; Gunnarsson U; Dahlstrand U; Lindforss U
Int J Colorectal Dis; 2018 May; 33(5):593-600. PubMed ID: 29508050
[TBL] [Abstract][Full Text] [Related]
38. Quality of Life and Timing of Stoma Closure in Patients With Rectal Cancer Undergoing Low Anterior Resection With Diverting Stoma: A Multicenter Longitudinal Observational Study.
Herrle F; Sandra-Petrescu F; Weiss C; Post S; Runkel N; Kienle P
Dis Colon Rectum; 2016 Apr; 59(4):281-90. PubMed ID: 26953986
[TBL] [Abstract][Full Text] [Related]
39. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.
Colombo PE; Mourregot A; Fabbro M; Gutowski M; Saint-Aubert B; Quenet F; Gourgou S; Rouanet P
Eur J Surg Oncol; 2009 Feb; 35(2):135-43. PubMed ID: 18289825
[TBL] [Abstract][Full Text] [Related]
40. Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center.
Muñoz-Casares FC; Medina-Fernández FJ; Arjona-Sánchez Á; Casado-Adam Á; Sánchez-Hidalgo JM; Rubio MJ; Ortega-Salas R; Muñoz-Villanueva MC; Rufián-Peña S; Briceño FJ
Eur J Surg Oncol; 2016 Feb; 42(2):224-33. PubMed ID: 26673283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
